antilymphocyte serum
Biologicalexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 1982 (NCT00000597)
Timeline
1980s
- Jan 1, 1982
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- antilymphocyte serum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00000597 | Phase 3 | Mar 1, 1982 | National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 1 | 1 | 1982 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 1982 |
2 organizations
Page 1 / 1